A complete application in a minute — tailored resume and cover letter, ready to send.
University Health Network seeks a Manager of Theranostics Innovation to build and scale a next‑gen theranostics program across clinical research, data, AI, and industry partnerships.
You will operationalize the Phase 0 clinical trials program, develop AI/data initiatives, and collaborate with industry, academia, and healthcare partners to advance theranostics delivery and study design.
UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital‑based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.
UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.
www.uhn.ca
Union: Non Union
Number of vacancies: 1
Replacement or New: New
Site: Toronto General Hospital
Department: Research
Reports to: Director, Translational Research and Innovation
Hours: 37.5 hours per week
Wage Range: $103,155 - $153,155 per annum
Status: Permanent Full Time
Closing Date: October 1, 2026
The Manager, Theranostics Innovation will play a central role in building and scaling a next-generation theranostics program at University Health Network (UHN). This role sits at the intersection of clinical research, data and AI innovation, and strategic industry partnerships. The successful candidate will help operationalize UHN’s Phase 0 clinical trials program, support the development of theranostics AI and data initiatives, and contribute to ecosystem-building activities with industry, academic, and healthcare partners. This is a unique opportunity to join a high-impact, fast-evolving program and help shape how theranostics is delivered, studied, and scaled within a leading global health system.
Why join UHN?
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN’s attendance management program, to be eligible for consideration.
UHN may conduct a Criminal Record Check. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.